[DOI] [Google Scholar] 85.Medvidovic-Grubisic M., Stambolija V., Kolenc D., Katancic J., Murselovic T., Plestina-Borjan I., Strbe S., Drmic D., Barisic I., Sindic A., et al
Routes: intravenous (IV), intramuscular (IM) Administration frequency: weekly to biweekly Duration: short-term cycles or maintenance protocols Infusion rate must be controlled to minimize adverse reactions
See more During the extensive two-year review process for the 2021 version of the Code, WADA received considerable stakeholder feedback related to drugs of abuse where it was felt that the use of some substances included in the Prohibited List was often unrelated to sport practice
however, dosing is less frequent, rebound is unlikely, and there is a longer remission time
GHK-Cu is injected subcutaneously into the abdomen, upper outer thigh, or back of the upper arm